Agilon Health
121 hedge funds and large institutions have $10.1B invested in Agilon Health in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 44 increasing their positions, 31 reducing their positions, and 36 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 31
0.01% more ownership
Funds ownership: 3.98% → 3.99% (+0.01%)
4% less capital invested
Capital invested by funds: $10.6B → $10.1B (-$429M)
8% less call options, than puts
Call options by funds: $15.4M | Put options by funds: $16.7M
8% less funds holding
Funds holding: 132 → 121 (-11)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
25% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$201M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$37.8M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$31.7M |
| 4 |
Morgan Stanley
New York
|
+$30.5M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$9.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$34.8M |
| 2 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
-$32.3M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$29.1M |
| 4 |
Jennison Associates
New York
|
-$17M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14.4M |
AGL Hedge Fund Activity: Q1 2022 in Review
121 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q1 2022, worth a combined $10.1B — down 4.1% from $10.6B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of AGL and 27 opened new positions — a net loss of 9 holders — while 31 trimmed existing stakes and 44 added.
The largest buyer was Fidelity Investments, adding an estimated $201M. The largest seller was BlackRock, cutting an estimated $34.8M.
- 121 institutional investors held Agilon Health (AGL) as of Q1 2022, down from 132 in Q4 2021.
- Funds reported $10.1B of Agilon Health stock for Q1 2022, down 4.1% quarter-over-quarter.
- 27 funds opened new Agilon Health positions in Q1 2022 and 36 closed out, a net change of -9 holders.
- The largest Agilon Health buyer in Q1 2022 was Fidelity Investments, an estimated $201M added.
- The largest Agilon Health seller in Q1 2022 was BlackRock, an estimated $34.8M sold.
Based on aggregated 13F filings for Q1 2022.